Cairo-Mubasher: Arab Drug Co. made EGP 4.6 million ($604,000) in net earnings including taxes during the 10-month period ended 30 April 2015, a rise of 19.5% compared with EGP 3.8 million ($499,000) a year earlier.

The company's sales increased from EGP 173.7 million to EGP 191.3 million.

Net earnings for the nine-month period until March 2015 amounted to EGP 3.184 million, compared with EGP 2.821 million in the corresponding period a year ago.

The drug producer operates with EGP 60 million in capital, divided into 6 million shares at a par value of EGP 10 each.